Discordant diagnostic criteria for pneumonia in COPD trials: a review

Inhaled corticosteroids (ICS) have a class effect of increasing pneumonia risk in patients with COPD. However, pneumonia incidence varies widely across clinical trials of ICS use in COPD. This review clarifies methodological differences in defining and recording pneumonia events in these trials and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wise, Robert A., Bafadhel, Mona, Crim, Courtney, Criner, Gerard J., Day, Nicola C., Halpin, David M.G., Han, MeiLan K., Lange, Peter, Lipson, David A., Martinez, Fernando J., Maselli, Diego J., Midwinter, Dawn, Singh, Dave, Zysman, Maeva, Dransfield, Mark T., Russell, Richard E.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488621/
https://www.ncbi.nlm.nih.gov/pubmed/34789465
http://dx.doi.org/10.1183/16000617.0124-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488621/
https://www.ncbi.nlm.nih.gov/pubmed/34789465
http://dx.doi.org/10.1183/16000617.0124-2021

Ejemplares similares